Singapore markets closed

PROCEPT BioRobotics Corporation (PRCT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
50.84-0.24 (-0.47%)
As of 10:31AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 2.60B
Enterprise value 2.42B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)17.71
Price/book (mrq)9.26
Enterprise value/revenue 17.79
Enterprise value/EBITDA -24.70

Trading information

Stock price history

Beta (5Y monthly) 1.01
52-week change 339.98%
S&P500 52-week change 321.23%
52-week high 354.50
52-week low 324.83
50-day moving average 349.08
200-day moving average 339.28

Share statistics

Avg vol (3-month) 3467.96k
Avg vol (10-day) 3542.31k
Shares outstanding 550.96M
Implied shares outstanding 650.96M
Float 843.88M
% held by insiders 13.62%
% held by institutions 191.67%
Shares short (28 Mar 2024) 44.65M
Short ratio (28 Mar 2024) 49.14
Short % of float (28 Mar 2024) 412.34%
Short % of shares outstanding (28 Mar 2024) 49.12%
Shares short (prior month 29 Feb 2024) 44.52M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -77.76%
Operating margin (ttm)-67.82%

Management effectiveness

Return on assets (ttm)-19.11%
Return on equity (ttm)-44.33%

Income statement

Revenue (ttm)136.19M
Revenue per share (ttm)2.88
Quarterly revenue growth (yoy)83.30%
Gross profit (ttm)N/A
EBITDA -105.36M
Net income avi to common (ttm)-105.9M
Diluted EPS (ttm)-2.24
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)257.22M
Total cash per share (mrq)5.05
Total debt (mrq)81.09M
Total debt/equity (mrq)28.88%
Current ratio (mrq)7.63
Book value per share (mrq)5.53

Cash flow statement

Operating cash flow (ttm)-108M
Levered free cash flow (ttm)-106.37M